Global Whole Genome Sequencing Market Assessment, By Product Type [Consumables, Instruments, Services], By Technology [Sanger Sequencing, Next Generation Sequencing, Polymerase Chain Reaction, Other Sequencing Technologies], By Organism [Humans, Plants, Animals, Microbes], By Application [Diagnostic Applications, Personalized Medicine, Research Applications], By End-Users [Hospitals and Healthcare Organizations, Academics and Research Institutions, Pharmaceutical and Biotechnology Companies, Others], By Region, Opportunities and Forecast, 2017-2031F

The global whole genome sequencing market is expected to increase due to increasing technological advancements, innovations, and need for precise diagnostic solutions.

Home>Industry Reports>Global Whole Genome Sequencing Market Assessment, Opportunities and Forecast, 2017-2031F

Global whole genome sequencing market size was valued at USD 3.44 billion in 2023 and is expected to reach USD 14.12 billion in 2031, with a CAGR of 19.31% for the forecast period between 2024 and 2031F. The ability of healthcare practitioners to precisely diagnose and predict chronic and genetic diseases, such as cancers and diabetes, which can help in the development of efficient treatment plans and disease management strategies, is acting as a major driver for the market growth.

Whole genome sequencing provides an early means of detecting genetic mutations that cause chronic disease. There is an increasing need for this industry since whole genome sequencing can be used to diagnose various chronic diseases and other genetic abnormalities, such as cystic fibrosis with high precision. Whole genome sequencing products are high in demand due to the growing number of genetic researchers working on various projects such as medication development, agricultural research, and forensics. The industry is anticipated to grow significantly as a result of government funding for scientific research and development as well as technological breakthroughs. However, the high cost associated with products, the lack of highly skilled professionals, and the interpretation of complicated data are some of the hindrances that can hamper the growth of the global whole genome sequencing market.

In March 2023, Illumina Inc. announced the launch of its first product based on its novel Illumina Complete Long Read technology. Illumina Inc. is a global provider of products used in DNA sequencing and array-based technologies. Illumina Complete Long Read Prep, Human is a high-performance, long-read, human whole-genome sequencing (WGS) assay that is compatible with Illumina NovaSeq X Plus, NovaSeq X, and NovaSeq 6000 Sequencing Systems. Illumina Complete Long Reads offers long and short-read sequencing in the same instrument for the first time and enable a simpler workflow as compared to other long-read offerings.

Growing Prevalence of Chronic Diseases and Genetic Disorders

The rising incidence of genetic abnormalities and chronic diseases significantly drives the market for whole genome sequencing. The rising incidence and prevalence of chronic illnesses such as cancer, cardiovascular diseases, and other conditions is fueling the need for whole genome sequencing-based diagnosis. The diagnosis and treatment of many disorders are greatly aided by whole genome sequencing, which has increased demand for related products and services. Whole genome sequencing techniques are becoming increasingly popular due to their ability to identify specific disease indicators and predict individual responses to therapies.

According to a factsheet updated by WHO in September 2023, noncommunicable diseases (NCDs) are responsible for killing 41 million people each year, equivalent to 74% of all deaths globally. Around 17 million people die from NCDs before the age of 70 years; 86% of these premature deaths occur in low- and middle-income countries. Cardiovascular diseases (CVDs) account for most NCD deaths, (17.9 million people annually), followed by cancers (9.3 million), chronic respiratory diseases (4.1 million), and diabetes (2.0 million).

Growing Research and Development

The global whole genome sequencing market is positively impacted by increasing research and development surrounding genome exploration and its various benefits applications. Over the past few decades, the human genome projects have significantly contributed to the growing body of research concerning genome explorations. The market is anticipated to rise significantly in collaboration with the growing acceptance and application of NGS and Sanger technology in institutional and academic research projects.

For instance, in November 2023, UK Biobank Limited released the world’s largest-by-far single set of sequencing data by investing EUR 200 million and conducted continuous research for five years into the public domain. The development of innovative diagnostics, therapies, and cures is expected to be fueled by this data. Researchers across the globe can access the data through a secure database that exclusively holds de-identified data.

Sanger Sequencing is Expected to Dominate During Forecast Period

For precise identification of single nucleotide mutations and minor insertions/deletions, Sanger sequencing is regarded as the gold standard. Sanger sequencing is preferred over other sequencing techniques due to its precision and accuracy. The segment is anticipated to lead the whole genome sequencing market's technology for the duration of the forecasted period due to the growing usage of Sanger sequencing. Numerous industry participants are committed to growing their businesses and offering more fast and accurate whole genome sequencing services.

In October 2023, Wellcome Sanger Institute announced the launch of ‘Generative and Synthetic Genomics Program’ to enhance research efforts on the ‘Human Genetics’ and ‘Tree of Life’ programs. By producing vast volumes of genomic data to feed into computer models will anticipate their consequences, such as the influence of mutations on disease, it seeks to bring together computational and experimental scientists to understand and forecast the impacts of editing DNA. Additionally, the researchers are expected to create tools for writing and editing genomes.

North America is Expected to Dominate the Market

North America is anticipated to dominate the market with the highest value share due to of its significant investment in R&D, technical breakthroughs made by major companies, and highly developed healthcare infrastructure in North American nations like the United States and Canada. Initiatives by the government are expected to expedite medication development process and cancer treatment, contributing to the market growth. In May 2023, The National Institutes of Health (NIH) launched a new program called Common Fund’s Somatic Mosaicism Across Human Tissues (SMaHT) Network worth USD 140 million to explore knowledge about genetic variation in normal human cells and tissues.

Report Scope

“Whole Genome Sequencing Market Assessment, Opportunities and Forecast, 2017-2031F”, is a comprehensive report by Markets and Data, providing in-depth analysis and qualitative and quantitative assessment of the current state of the whole genome sequencing market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, opportunities and forecast between 2024 and 2031F. Additionally, the report profiles the leading players in the industry mentioning their respective market share, business model, competitive intelligence, etc.

Report Attribute

Details

Base Year of the Analysis

2023

Historical Period

2017-2022

Forecast Period

2024-2031F

Projected Growth Rate

CAGR of 19.31% between 2024 and 2031F

Revenue Forecast in 2031

USD 14.12 billion

Units

Revenue in USD billion

Segments Covered

Product Type, Technology, Organism, Application, End-users

Regions Covered

North America, Europe, Asia-Pacific, Middle East, and Africa, South America

Key Companies Profiled

Illumina, Inc., Thermo Fisher Scientific Inc., BGI Genomics Co Ltd, Agilent Technologies Inc., 10x Genomics, Inc., Qiagen NV, F. Hoffmann-La Roche Ltd, Merck KGaA, PerkinElmer Inc., Myriad Genetics Inc., Oxford Nanopore Technologies plc

Customization Scope

15% free report customization with purchase

Pricing and Purchase Options

Avail the customized purchase options to fulfill your precise research needs

Delivery Format

PDF and Excel through email (subject to the license purchased)

In this report, global whole genome sequencing market has been segmented into the following categories: 

·         By Product Type

o   Consumables

o   Instruments

o   Services

·         By Technology

o   Sanger Sequencing

o   Next-Generation Sequencing

o   Polymerase Chain Reaction

o   Other Sequencing Technologies

·         By Organism

o   Humans

o   Plants

o   Animals

o   Microbes

·         By Application

o   Diagnostic Applications

o   Personalized Medicine

o   Research Applications

§  Forensics

§  Agriculture

§  Drug Development

§  Others

·         By End-users

o   Hospitals and Healthcare Organizations

o   Academics and Research Institutions

o   Pharmaceutical and Biotechnology Companies

o   Others

·         By Region

o   North America

o   Europe

o   Asia Pacific

o   South America

o   Middle East & Africa

Key Players Landscape and Outlook

Market players are expanding their product offerings and giving their customers access to a wide range of cutting-edge and novel products using various strategies. Companies are expanding the range of products they offer to gain market share. Industry participants are using a variety of growth methods, including collaborations, mergers and acquisitions, product launches, and the development of new goods, to bolster their positions in the market.

In July 2023, MedGenome announced the acquisition of Illumina's NovaSeq X Plus. MedGenome is a leading global genomic diagnostic and research services organization in South Asia. The acquisition makes MedGenome the first to offer advanced genomics services using Illumina's NovaSeq X Plus in South Asia. Through the acquisition, the company anticipates cutting down the reagent cost of human whole genome sequencing to USD 200. MedGenome announced the launch of KaryoSeq (or Karyotype Sequencing), which is an innovative whole genome sequencing to diagnose prenatal and newborn conditions.

Key Players Operating in Global Whole Genome Sequencing Market are:

·         Illumina, Inc.,

·         Thermo Fisher Scientific Inc.

·         BGI Genomics Co Ltd

·         Agilent Technologies Inc.

·         10x Genomics, Inc.

·         Qiagen NV

·         F. Hoffmann-La Roche Ltd

·         Merck KGaA

·         PerkinElmer Inc.

·         Myriad Genetics Inc.

·         Oxford Nanopore Technologies plc

Markets and Data’s reports answer the following questions:

·         What is the current and future market size of the product/service in question globally or specific to different countries?

·         How are the markets divided into different product/service segments and the market size and growth of each segment?

·         What is the market potential of different product segments and their investment case?

·         How are the markets predicted to develop in the future and what factors will drive or inhibit growth?

·         What is the business environment and regulatory landscape specific to the product/service?

If you can't find what you're searching for or have any custom requirements for global whole genome sequencing market, you may approach our team at info@marketsandata.com

Table of Contents

1.       Research Methodology

2.       Project Scope & Definitions

3.       Executive Summary

4.       Global Whole Genome Sequencing Market Outlook, 2017-2031F

4.1.    Market Size & Forecast

4.1.1.By Value

4.1.2.By Volume

4.2.    By Product Type

4.2.1.Consumables

4.2.2.Instruments

4.2.3.Services

4.3.    By Technology

4.3.1.Sanger Sequencing

4.3.2.Next-Generation Sequencing

4.3.3.Polymerase Chain Reaction

4.3.4.Other Sequencing Technologies

4.4.    By Organism

4.4.1.Humans

4.4.2.Plants

4.4.3.Animals

4.4.4.Microbes

4.5.    By Application

4.5.1.Diagnostic Applications

4.5.2.Personalized Medicine

4.5.3.Research Applications

4.5.3.1.              Forensics

4.5.3.2.              Agriculture

4.5.3.3.              Drug Development

4.5.3.4.              Others

4.6.    By End-users

1.1.1.Hospitals and Healthcare Organizations

1.1.2.Academics and Research Institutions

1.1.3.Pharmaceutical and Biotechnology Companies

1.1.4.Others

4.7.    By Region

4.7.1.North America

4.7.2.Europe

4.7.3.Asia Pacific

4.7.4.South America

4.7.5.Middle East & Africa

4.8.    By Company Market Share (%), 2023

5.       Global Whole Genome Sequencing Market, 2017-2031F

5.1.   North America*

5.1.1.Market Size & Forecast

5.1.1.1.              By Value

5.1.1.2.              By Volume

5.1.2.By Product Type

5.1.2.1.              Consumables

5.1.2.2.              Instruments

5.1.2.3.              Services

5.1.3.By Technology

5.1.3.1.              Sanger Sequencing

5.1.3.2.              Next-Generation Sequencing

5.1.3.3.              Polymerase Chain Reaction

5.1.3.4.              Other Sequencing Technologies

5.1.4.By Organism

5.1.4.1.              Humans

5.1.4.2.              Plants

5.1.4.3.              Animals

5.1.4.4.              Microbes

5.1.5.By Application

5.1.5.1.              Diagnostic Applications

5.1.5.2.              Personalized Medicine

5.1.5.3.              Research Applications

5.1.5.3.1.                    Forensics

5.1.5.3.2.                    Agriculture

5.1.5.3.3.                    Drug Development

5.1.5.3.4.                    Others

5.1.6.By End-users

5.1.6.1.              Hospitals and Healthcare Organizations

5.1.6.2.              Academics and Research Institutions

5.1.6.3.              Pharmaceutical and Biotechnology Companies

5.1.6.4.              Others

5.1.7.United States*

5.1.7.1.              Market Size & Forecast

5.1.7.1.1.                    By Value

5.1.7.1.2.                    By Volume

5.1.7.2.              By Product Type

5.1.7.2.1.                    Consumables

5.1.7.2.2.                    Instruments

5.1.7.2.3.                    Services

5.1.7.3.              By Technology

5.1.7.3.1.                    Sanger Sequencing

5.1.7.3.2.                    Next-Generation Sequencing

5.1.7.3.3.                    Polymerase Chain Reaction

5.1.7.3.4.                    Other Sequencing Technologies

5.1.7.4.              By Organism

5.1.7.4.1.                    Humans

5.1.7.4.2.                    Plants

5.1.7.4.3.                    Animals

5.1.7.4.4.                    Microbes

5.1.7.5.              By Application

5.1.7.5.1.                    Diagnostic Applications

5.1.7.5.2.                    Personalized Medicine

5.1.7.5.3.                    Research Applications

5.1.7.5.3.1.   Forensics

5.1.7.5.3.2.   Agriculture

5.1.7.5.3.3.   Drug Development

5.1.7.5.3.4.   Others

5.1.7.6.              By End-users

5.1.7.6.1.                    Hospitals and Healthcare Organizations

5.1.7.6.2.                    Academics and Research Institutions

5.1.7.6.3.                    Pharmaceutical and Biotechnology Companies

5.1.7.6.4.                    Others

5.1.8.Canada

5.1.9.Mexico

*All segments will be provided for all regions and countries covered

5.2.   Europe

5.2.1.Germany

5.2.2.France

5.2.3.Italy

5.2.4.United Kingdom

5.2.5.Russia

5.2.6.Netherlands

5.2.7.Spain

5.2.8.Turkey

5.2.9.Poland

5.3.   South America

5.3.1.Brazil

5.3.2.Argentina

5.4.   Asia-Pacific

5.4.1.India

5.4.2.China

5.4.3.Japan

5.4.4.Australia

5.4.5.Vietnam

5.4.6.South Korea

5.4.7.Indonesia

5.4.8.Philippines

5.5.   Middle East & Africa

5.5.1.Saudi Arabia

5.5.2.UAE

5.5.3.South Africa

6.       Market Mapping, 2023

6.1.    By Type

6.2.    By Technology

6.3.    By Organism

6.4.    By Application

6.5.    By End-users

6.6.    By Region

7.       Macro Environment and Industry Structure

7.1.    Supply Demand Analysis

7.2.    Import Export Analysis – Volume and Value

7.3.    Supply/Value Chain Analysis

7.4.    PESTEL Analysis

7.4.1.Political Factors

7.4.2.Economic System

7.4.3.Social Implications

7.4.4.Technological Advancements

7.4.5.Environmental Impacts

7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)

7.5.    Porter’s Five Forces Analysis

7.5.1.Supplier Power

7.5.2.Buyer Power

7.5.3.Substitution Threat

7.5.4.Threat from New Entrant

7.5.5.Competitive Rivalry

8.       Market Dynamics

8.1.    Growth Drivers

8.2.    Growth Inhibitors (Challenges, Restraints)

9.       Regulatory Framework and Innovation

9.1.    Clinical Trials

9.2.    Patent Landscape

9.3.    Regulatory Approvals

9.4.    Innovations/Emerging Technologies

10.   Key Players Landscape

10.1.                     Competition Matrix of Top Five Market Leaders

10.2.                     Market Revenue Analysis of Top Five Market Leaders (in %, 2023)

10.3.                     Mergers and Acquisitions/Joint Ventures (If Applicable)

10.4.                     SWOT Analysis (For Five Market Players)

10.5.                     Patent Analysis (If Applicable)

11.   Pricing Analysis

12.   Case Studies

13.   Key Players Outlook

13.1.                     Illumina, Inc.,

13.1.1.    Company Details

13.1.2.    Key Management Personnel

13.1.3.    Products & Services

13.1.4.    Financials (As reported)

13.1.5.    Key Market Focus & Geographical Presence

13.1.6.    Recent Developments

13.2.                     Thermo-Fischer scientific

13.3.                     BGI genomics

13.4.                     Agilent Technologies Inc.

13.5.                     10X Genomics

13.6.                     QIAGEN

13.7.                     F. Hoffmann-La Roche Ltd

13.8.                     Merck KGaA

13.9.                     PerkinElmer Inc.

13.10.                  Myriad Genetics Inc.

*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14.   Strategic Recommendations

15.   About Us & Disclaimer

List of Figures

Figure 1. Global Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F

Figure 2. Global Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F

Figure 3. Global Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F

Figure 4. Global Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F

Figure 5. Global Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F

Figure 6. Global Whole Genome Sequencing Market Share (%), By Application, 2017-2031F

Figure 7. Global Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F

Figure 8. Global Whole Genome Sequencing Market Share (%), By Region, 2017-2031F

Figure 9. North America Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F

Figure 10. North America Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F

Figure 11. North America Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F

Figure 12. North America Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F

Figure 13. North America Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F

Figure 14. North America Whole Genome Sequencing Market Share (%), By Application, 2017-2031F

Figure 15. North America Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F

Figure 16. North America Whole Genome Sequencing Market Share (%), By Country, 2017-2031F

Figure 17. United States Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F

Figure 18. United States Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F

Figure 19. United States Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F

Figure 20. United States Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F

Figure 21. United States Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F

Figure 22. United States Whole Genome Sequencing Market Share (%), By Application, 2017-2031F

Figure 23. United States Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F

Figure 24. Canada Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F

Figure 25. Canada Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F

Figure 26. Canada Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F

Figure 27. Canada Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F

Figure 28. Canada Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F

Figure 29. Canada Whole Genome Sequencing Market Share (%), By Application, 2017-2031F

Figure 30. Canada Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F

Figure 31. Mexico Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F

Figure 32. Mexico Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F

Figure 33. Mexico Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F

Figure 34. Mexico Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F

Figure 35. Mexico Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F

Figure 36. Mexico Whole Genome Sequencing Market Share (%), By Application, 2017-2031F

Figure 37. Mexico Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F

Figure 38. Europe Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F

Figure 39. Europe Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F

Figure 40. Europe Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F

Figure 41. Europe Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F

Figure 42. Europe Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F

Figure 43. Europe Whole Genome Sequencing Market Share (%), By Application, 2017-2031F

Figure 44. Europe Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F

Figure 45. Europe Whole Genome Sequencing Market Share (%), By Country, 2017-2031F

Figure 46. Germany Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F

Figure 47. Germany Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F

Figure 48. Germany Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F

Figure 49. Germany Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F

Figure 50. Germany Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F

Figure 51. Germany Whole Genome Sequencing Market Share (%), By Application, 2017-2031F

Figure 52. Germany Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F

Figure 53. France Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F

Figure 54. France Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F

Figure 55. France Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F

Figure 56. France Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F

Figure 57. France Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F

Figure 58. France Whole Genome Sequencing Market Share (%), By Application, 2017-2031F

Figure 59. France Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F

Figure 60. Italy Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F

Figure 61. Italy Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F

Figure 62. Italy Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F

Figure 63. Italy Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F

Figure 64. Italy Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F

Figure 65. Italy Whole Genome Sequencing Market Share (%), By Application, 2017-2031F

Figure 66. Italy Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F

Figure 67. United Kingdom Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F

Figure 68. United Kingdom Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F

Figure 69. United Kingdom Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F

Figure 70. United Kingdom Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F

Figure 71. United Kingdom Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F

Figure 72. United Kingdom Whole Genome Sequencing Market Share (%), By Application, 2017-2031F

Figure 73. United Kingdom Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F

Figure 74. Russia Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F

Figure 75. Russia Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F

Figure 76. Russia Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F

Figure 77. Russia Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F

Figure 78. Russia Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F

Figure 79. Russia Whole Genome Sequencing Market Share (%), By Application, 2017-2031F

Figure 80. Russia Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F

Figure 81. Netherlands Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F

Figure 82. Netherlands Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F

Figure 83. Netherlands Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F

Figure 84. Netherlands Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F

Figure 85. Netherlands Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F

Figure 86. Netherlands Whole Genome Sequencing Market Share (%), By Application, 2017-2031F

Figure 87. Netherlands Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F

Figure 88. Spain Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F

Figure 89. Spain Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F

Figure 90. Spain Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F

Figure 91. Spain Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F

Figure 92. Spain Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F

Figure 93. Spain Whole Genome Sequencing Market Share (%), By Application, 2017-2031F

Figure 94. Spain Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F

Figure 95. Turkey Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F

Figure 96. Turkey Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F

Figure 97. Turkey Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F

Figure 98. Turkey Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F

Figure 99. Turkey Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F

Figure 100. Turkey Whole Genome Sequencing Market Share (%), By Application, 2017-2031F

Figure 101. Turkey Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F

Figure 102. Poland Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F

Figure 103. Poland Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F

Figure 104. Poland Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F

Figure 105. Poland Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F

Figure 106. Poland Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F

Figure 107. Poland Whole Genome Sequencing Market Share (%), By Application, 2017-2031F

Figure 108. Poland Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F

Figure 109. South America Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F

Figure 110. South America Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F

Figure 111. South America Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F

Figure 112. South America Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F

Figure 113. South America Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F

Figure 114. South America Whole Genome Sequencing Market Share (%), By Application, 2017-2031F

Figure 115. South America Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F

Figure 116. South America Whole Genome Sequencing Market Share (%), By Country, 2017-2031F

Figure 117. Brazil Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F

Figure 118. Brazil Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F

Figure 119. Brazil Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F

Figure 120. Brazil Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F

Figure 121. Brazil Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F

Figure 122. Brazil Whole Genome Sequencing Market Share (%), By Application, 2017-2031F

Figure 123. Brazil Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F

Figure 124. Argentina Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F

Figure 125. Argentina Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F

Figure 126. Argentina Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F

Figure 127. Argentina Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F

Figure 128. Argentina Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F

Figure 129. Argentina Whole Genome Sequencing Market Share (%), By Application, 2017-2031F

Figure 130. Argentina Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F

Figure 131. Asia-Pacific Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F

Figure 132. Asia-Pacific Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F

Figure 133. Asia-Pacific Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F

Figure 134. Asia-Pacific Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F

Figure 135. Asia-Pacific Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F

Figure 136. Asia-Pacific Whole Genome Sequencing Market Share (%), By Application, 2017-2031F

Figure 137. Asia- Pacific Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F

Figure 138. Asia-Pacific Whole Genome Sequencing Market Share (%), By Country, 2017-2031F

Figure 139. India Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F

Figure 140. India Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F

Figure 141. India Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F

Figure 142. India Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F

Figure 143. India Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F

Figure 144. India Whole Genome Sequencing Market Share (%), By Application, 2017-2031F

Figure 145. India Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F

Figure 146. China Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F

Figure 147. China Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F

Figure 148. China Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F

Figure 149. China Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F

Figure 150. China Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F

Figure 151. China Whole Genome Sequencing Market Share (%), By Application, 2017-2031F

Figure 152. China Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F

Figure 153. Japan Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F

Figure 154. Japan Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F

Figure 155. Japan Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F

Figure 156. Japan Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F

Figure 157. Japan Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F

Figure 158. Japan Whole Genome Sequencing Market Share (%), By Application, 2017-2031F

Figure 159. Japan Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F

Figure 160. Australia Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F

Figure 161. Australia Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F

Figure 162. Australia Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F

Figure 163. Australia Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F

Figure 164. Australia Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F

Figure 165. Australia Whole Genome Sequencing Market Share (%), By Application, 2017-2031F

Figure 166. Australia Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F

Figure 167. Vietnam Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F

Figure 168. Vietnam Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F

Figure 169. Vietnam Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F

Figure 170. Vietnam Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F

Figure 171. Vietnam Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F

Figure 172. Vietnam Whole Genome Sequencing Market Share (%), By Application, 2017-2031F

Figure 173. Vietnam Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F

Figure 174. South Korea Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F

Figure 175. South Korea Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F

Figure 176. South Korea Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F

Figure 177. South Korea Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F

Figure 178. South Korea Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F

Figure 179. South Korea Whole Genome Sequencing Market Share (%), By Application, 2017-2031F

Figure 180. South Korea Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F

Figure 181. Indonesia Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F

Figure 182. Indonesia Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F

Figure 183. Indonesia Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F

Figure 184. Indonesia Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F

Figure 185. Indonesia Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F

Figure 186. Indonesia Whole Genome Sequencing Market Share (%), By Application, 2017-2031F

Figure 187. Indonesia Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F

Figure 188. Philippines Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F

Figure 189. Philippines Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F

Figure 190. Philippines Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F

Figure 191. Philippines Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F

Figure 192. Philippines Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F

Figure 193. Philippines Whole Genome Sequencing Market Share (%), By Application, 2017-2031F

Figure 194. Philippines Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F

Figure 195. Middle East & Africa Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F

Figure 196. Middle East & Africa Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F

Figure 197. Middle East & Africa Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F

Figure 198. Middle East & Africa Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F

Figure 199. Middle East & Africa Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F

Figure 200. Middle East & Africa Whole Genome Sequencing Market Share (%), By Application, 2017-2031F

Figure 201. Middle East & Africa Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F

Figure 202. Middle East & Africa Whole Genome Sequencing Market Share (%), By Country, 2017-2031F

Figure 203. Saudi Arabia Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F

Figure 204. Saudi Arabia Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F

Figure 205. Saudi Arabia Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F

Figure 206. Saudi Arabia Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F

Figure 207. Saudi Arabia Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F

Figure 208. Saudi Arabia Whole Genome Sequencing Market Share (%), By Application, 2017-2031F

Figure 209. Saudi Arabia Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F

Figure 210. UAE Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F

Figure 211. UAE Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F

Figure 212. UAE Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F

Figure 213. UAE Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F

Figure 214. UAE Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F

Figure 215. UAE Whole Genome Sequencing Market Share (%), By Application, 2017-2031F

Figure 216. UAE Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F

Figure 217. South Africa Whole Genome Sequencing Market, By Value, In USD Billion, 2017-2031F

Figure 218. South Africa Whole Genome Sequencing Market, By Volume, In Thousand Units, 2017-2031F

Figure 219. South Africa Whole Genome Sequencing Market Share (%), By Product Type, 2017-2031F

Figure 220. South Africa Whole Genome Sequencing Market Share (%), By Technology, 2017-2031F

Figure 221. South Africa Whole Genome Sequencing Market Share (%), By Organism, 2017-2031F

Figure 222. South Africa Whole Genome Sequencing Market Share (%), By Application, 2017-2031F

Figure 223. South Africa Whole Genome Sequencing Market Share (%), By End-users, 2017-2031F

Figure 224. By Product Type Map-Market Size (USD Billion) & Growth Rate (%), 2023

Figure 225. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023

Figure 226. By Organism Map-Market Size (USD Billion) & Growth Rate (%), 2023

Figure 227. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023

Figure 228. By End-users Map-Market Size (USD Billion) & Growth Rate (%), 2023

Figure 229. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023 

List of Tables

Table 1. Pricing Analysis of Products from Key Players

Table 2. Competition Matrix of Top 5 Market Leaders

Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)

Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

Frequently Asked Questions

What regions are covered in the final report of global whole genome sequencing market?

arrowup
Heart

Global Body and Hair Mist Market Assessment, Opportunities and Forecast, 2017-2031F

Global body and hair mist market is anticipated to grow due to expansion of retail distribution channel which makes it accessible for the consumers to get their hands on the latest launches of body and hair mists in the market and consumers’ preferen....Read More

Published on

June 2024

4,500

Heart

Global Body Wash and Shower Gel Market Assessment, Opportunities and Forecast, 2017-2031F

Global body wash and shower gel market is witnessing exponential growth due to increasing demand for fragrance-free, cruelty-free, mild, and organic body washes and shower gels. Additionally, consumers preference for gentle and hydrating products to ....Read More

Published on

June 2024

4,500

Heart

Global Children’s Footwear Market Assessment, Opportunities and Forecast, 2017-2031F

Global children’s footwear market is witnessing growth due to consumers’ increasing preference for comfortable and functional footwear which promotes healthy feet of children, their participation in sports and outdoor activities, and increasing deman....Read More

Published on

June 2024

4,500

Heart

Global Intimate Wash Care Products Market Assessment, Opportunities and Forecast, 2017-2031F

Global intimate wash care products market is anticipated to grow due to consumers’ increasing awareness of the importance of cleanliness in the intimate area to eliminate the risk of infection and bacterial growth and introduction of different format....Read More

Published on

June 2024

4,500

Purchase Options

USD ($)

arrowdown

i

3,000

i

4,500

i

5,700

i

8,200

Tired of Searching?

Looking for Customization?

Some other doubt?

Need insights from a cohort?

REACH US

    icon_Five
    17, Okhla Industrial Estate Phase 3 Rd, Okhla Phase III, Okhla Industrial Estate, New Delhi, Delhi 110020
    call_Two
    +91 11 42343567
    icon_Six
    info@marketsandata.com
icon_Seven
5741 Cleveland street, Suite 120, VA beach, VA, USA 23462
call_Three
+1 (757) 343-3258
icon_Eight
190 Middle Road, # 14-10 Fortune Centre, Singapore -188979